 A randomized, double-blind, parallel group, placebo and active prednisone controlled, 6-week study of the effect of GW685698X aqueous nasal spray 100mcg QD on the hypothalamic pituitary adrenocortical HPA axis in adolescents and adults 12 to 65 years of age with perennial allergic rhinitis PAR. 